Skip to Content

Prestalia Approval History

  • FDA approved: Yes (First approved January 21st, 2015)
  • Brand name: Prestalia
  • Generic name: amlodipine besylate and perindopril arginine
  • Dosage form: Tablets
  • Company: Symplmed
  • Treatment for: High Blood Pressure

Prestalia (amlodipine besylate and perindopril arginine) is a calcium channel blocker and long-acting angiotensin-converting enzyme (ACE) inhibitor combination for the treatment of hypertension.

Development History and FDA Approval Process for Prestalia

DateArticle
Jan 22, 2015Approval FDA Approves Prestalia (amlodipine and perindopril) for Hypertension
Jun 17, 2014FDA Accepts New Drug Application for Symplmed’s Prestalia for the Treatment of Hypertension

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide